Patents expiring in 2033

US 8492378

GSK-3β inhibitor

Takeda Pharmaceutical Company Limited · Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8492397

Aminopyridine derivatives having Aurora A selective inhibitory action

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8492405

Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity

Takeda Pharmaceutical Company Limited · Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497258

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

The Regents of the University of California · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497249

Fungicidal properties of three saponins from Capsicum frutescens

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8496938

Anti-CD100 neutralizing neutralizing antibodies and methods of using the same

VACCINEX, INC. · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497274

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497290

Thiocolchicine derivatives, method of making and methods of use thereof

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497381

Antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497357

Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom

Nektar Therapeutics · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497295

Spiroindoline modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8496957

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497279

Treatment for discoid lupus

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497393

Process to prepare treprostinil, the active ingredient in Remodulin®

United Therapeutics Corporation · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497307

Aryl guanidine F1F0-ATPase inhibitors and related methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497287

Aminotetralin compounds as mu opioid receptor antagonists

Theravance, Inc. · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497241

WNT10-derived peptide and use thereof

CAREGEN CO., LTD. · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497271

Modulators of G protein-coupled receptor 88

LEXICON PHARMACEUTICALS, INC. · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8497301

Hydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2620148

Antitumorkombination mit Cabazitaxel und Cisplatin

AVENTIS PHARMA SA [FR] · Granted Wed Jul 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jul 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

MX 2013007491

GRANULATES COMPRISING ESLICARBAZEPINE ACETATE.

BIAL PORTELA & CA SA [PT] · Granted Thu Aug 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jul 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501404

Gnaq mutations in melanoma

The Regents of the University of California · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501446

Azaindoles useful as inhibitors of JAK and other protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501686

Method of treating fatty liver diseases and conditions in non-lipodystrophic subjects

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501776

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501798

Dual-acting antihypertensive agents

Theravance, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501920

Nucleic acid sequences encoding peptides with utrophin spectrin-like repeats

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501926

Malaria vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501953

PKM2 modulators for use in the treatment of cancer

Agios Pharmaceuticals, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501964

Serotonin reuptake inhibitors

Theravance, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

BR PI0714667

conjugado molecular e respectivo uso

CERAMOPTEC IND INC [US] · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501247

Pest control using natural pest control agent blends

TYRATECH, INC. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501804

Bicyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501722

Methods and compositions for treating bacterial infection

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501188

Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501191

FGFR2-IIIb fusion proteins and methods of making them

Five Prime Therapeutics, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501229

Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings

ATRIUM MEDICAL CORPORATION · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501194

Vaccine for viruses that cause persistent or latent infections

The Regents of the University of California · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501423

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

The Board of Regents of the University of Texas System · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501678

Variant activin receptor polypeptides and uses thereof

Atara Biotherapeutics, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501466

Vector

The Pirbright Institute · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501681

Macrocyclic hepatitis C virus serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501682

Difluorinated tripeptides as HCV serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501692

Compositions and methods for altering cocaine esterase activity

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501705

Methods and materials for treating autoimmune and/or complement mediated diseases and conditions

The Board of Regents of the University of Texas System · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501695

Tissue kallikrein for the treatment of diseases associated with amyloid protein

DiaMedica Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501688

SCGB3A2 as a growth factor and anti-apoptotic agent

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8501704

Immunosuppression compound and treatment method

Sarepta Therapeutics, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)